C4 Therapeutics (CCCC)
NASDAQ:CCCC
Want to see CCCC full AI Analyst Report?
C4 Therapeutics (CCCC) Ownership Overview
3.36% Insiders
9.85% Mutual Funds
11.17% Other Institutional Investors
6.55% ETFs
69.06% Public Companies and
Individual Investors
The ownership structure of C4 Therapeutics (CCCC) stock is a mix of institutional, retail, and individual investors. Approximately 27.58% of the company’s stock is owned by Institutional Investors, 3.36% is owned by Insiders, and 69.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 16, 2026 | xxxxxxxxxxxxx | $22200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $195198 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $15280000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,000,000 | Institution | 8.20% | 24,280,000 | |
| 4,553,793 | Institution | 4.67% | 13,820,762 | |
| 3,775,357 | Institution | 3.87% | 11,458,208 | |
| 3,775,357 | Institution | 3.87% | 11,458,208 | |
| 1,074,934 | Insider | 1.10% | 3,262,425 | |
| 920,899 | Institution | 0.94% | 2,794,928 | |
| 723,610 | Institution | 0.74% | 2,196,156 | |
| 580,248 | Institution | 0.59% | 1,761,053 | |
| 411,062 | Institution | 0.42% | 1,247,573 | |
| 385,098 | Insider | 0.39% | 1,168,772 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,553,793 | Institution | 4.67% | 13,820,762 | |
| 3,775,357 | Institution | 3.87% | 11,458,208 | |
| 723,610 | Institution | 0.74% | 2,196,156 | |
| 120,000 | Institution | 0.12% | 364,200 | |
| 75,400 | Institution | 0.08% | 228,839 | |
| 74,120 | Institution | 0.08% | 224,954 | |
| 55,192 | Institution | 0.06% | 167,508 | |
| 45,085 | Institution | 0.05% | 136,833 | |
| 41,410 | Institution | 0.04% | 125,679 | |
| 40,958 | Institution | 0.04% | 124,308 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,892,424 | Institution | 2.96% | 7,607,075 | |
| 882,933 | Institution | 0.90% | 2,322,114 | |
| 599,977 | Institution | 0.61% | 1,820,930 | |
| 579,738 | Institution | 0.59% | 1,692,835 | |
| 383,591 | Institution | 0.39% | 1,164,199 | |
| 321,952 | Institution | 0.33% | 940,100 | |
| 212,398 | Institution | 0.22% | 644,628 | |
| 189,897 | Institution | 0.19% | 576,337 | |
| 88,303 | Institution | 0.09% | 268,000 | |
| 64,888 | Institution | 0.07% | 183,633 |
FAQ
Who Owns C4 Therapeutics (CCCC)?
According to the latest TipRanks data, approximately 11.17% of the company's stock is held by institutional investors, 3.36% is held by insiders, and 69.06% is held by retail investors.
What percentage of C4 Therapeutics (CCCC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.17% of C4 Therapeutics (CCCC) stock is held by institutional investors.
What percentage of C4 Therapeutics (CCCC) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.06% of C4 Therapeutics (CCCC) stock is held by retail investors.
Who owns the most shares of C4 Therapeutics (CCCC)?
Peter Kolchinsky owns the most shares of C4 Therapeutics (CCCC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.